Gene Alias
Anti-PRAME Immunotherapeutic GSK2302032A
Background
Description: An immunotherapeutic agent targeting the tumor-associated antigen (TAA), preferentially expressed antigen of melanoma (PRAME), with potential antineoplastic activity. (NCIT_C116848).